Solventum Corp. (SOLV)
80.09
-2.51
(-3.04%)
USD |
NYSE |
Dec 09, 16:00
80.09
0.00 (0.00%)
After-Hours: 16:00
Solventum EPS Diluted (Quarterly): 7.218 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Baxter International, Inc. | 0.0175 |
| Becton, Dickinson & Co. | 1.717 |
| ResMed, Inc. | 2.373 |
| Dentsply Sirona, Inc. | -2.140 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.266B |
| Revenue (Quarterly) | 2.096B |
| Total Expenses (Quarterly) | 830.00M |
| Enterprise Value | 17.82B |
| Gross Profit Margin (Quarterly) | 53.91% |
| Profit Margin (Quarterly) | 60.40% |
| Earnings Yield | 10.85% |
| Operating Earnings Yield | 7.41% |
| Normalized Earnings Yield | 13.02 |